Centene Corporation $CNC Shares Acquired by Cibc World Market Inc.

Cibc World Market Inc. lifted its stake in Centene Corporation (NYSE:CNC) by 909.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 421,168 shares of the company’s stock after purchasing an additional 379,428 shares during the period. Cibc World Market Inc.’s holdings in Centene were worth $15,027,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. UniSuper Management Pty Ltd increased its position in shares of Centene by 66.0% in the third quarter. UniSuper Management Pty Ltd now owns 85,232 shares of the company’s stock valued at $3,041,000 after buying an additional 33,875 shares in the last quarter. Packer & Co Ltd acquired a new stake in Centene in the 3rd quarter valued at about $50,487,000. First Citizens Bank & Trust Co. increased its holdings in Centene by 122.5% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 223,157 shares of the company’s stock valued at $7,962,000 after acquiring an additional 122,870 shares in the last quarter. ARGA Investment Management LP acquired a new position in Centene during the third quarter worth about $21,485,000. Finally, Amundi lifted its holdings in shares of Centene by 6.2% in the second quarter. Amundi now owns 3,384,752 shares of the company’s stock valued at $183,724,000 after purchasing an additional 199,016 shares in the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.

More Centene News

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Deutsche Bank raised its price target to $39, signaling some support for the stock from the Street. Deutsche Bank Boosts Price Target
• Positive Sentiment: Value-oriented writeups (Zacks and MSN) highlight Centene as a long‑term value pick, which can attract buy‑and‑hold investors looking past near‑term volatility. Zacks Value Stock Article
• Positive Sentiment: Ambetter Health (a Centene brand) completed a new community playground with KABOOM! and the City of Hialeah — a reputation/ESG positive that supports member/community goodwill but is unlikely to move near‑term earnings. Ambetter Playground PR
• Positive Sentiment: Superior HealthPlan and the Centene Foundation expanded the “No One Eats Alone” program in Texas schools — another CSR item that supports brand and member engagement. NOEA Initiative PR
• Neutral Sentiment: TD Cowen raised its price target to $38 but maintained a “hold,” a modestly constructive move that still signals limited upside in the near term. TD Cowen PT Raise
• Neutral Sentiment: Argus moved Centene to a “hold” and Cantor Fitzgerald reaffirmed “neutral” — multiple firms keeping conservative stances that limit buying pressure. Argus Hold / Zacks Reference
• Neutral Sentiment: Guggenheim issued a “hold” on Centene, reinforcing the Street’s broadly cautious stance. Guggenheim Hold
• Negative Sentiment: A detailed piece on Centene’s 2025 loss and the 2026 outlook raises concerns that recent losses and forward guidance could materially change investor expectations and valuation — this coverage likely pressures the stock. 2025 Loss / 2026 Outlook Article

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on CNC shares. Zacks Research upgraded Centene from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 29th. Argus upgraded Centene to a “hold” rating in a research report on Monday. JPMorgan Chase & Co. lifted their price objective on Centene from $38.00 to $45.00 and gave the stock a “neutral” rating in a research report on Thursday, January 22nd. UBS Group set a $42.00 target price on shares of Centene and gave the company a “neutral” rating in a report on Thursday, October 30th. Finally, TD Cowen lifted their price target on shares of Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a report on Wednesday. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $41.50.

Centene Price Performance

Centene stock opened at $39.17 on Friday. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $66.03. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.08 and a current ratio of 1.10. The firm has a 50 day moving average price of $42.08 and a 200 day moving average price of $36.20. The company has a market cap of $19.25 billion, a price-to-earnings ratio of -2.88, a PEG ratio of 0.90 and a beta of 0.48.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. The company had revenue of $49.73 billion for the quarter, compared to analyst estimates of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. Centene’s revenue for the quarter was up 21.9% on a year-over-year basis. During the same quarter last year, the business earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Sell-side analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.